RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Colomer Bosch, Ramon ramon.colomer@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

Gemcitabine in combination with paclitaxel for the treatment of metastatic breast cancer

  • Ramon Colomer

Women's Health (London, England) (p. 323-329) - 1/11/2005

10.2217/17455057.1.3.323 View at source

  • ISSN 17455065

Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue: Item Generation and Item Reduction

  • Baro, Eva
  • Carulla, Joan
  • Cassinello, Javier
  • Colomer, Ramon
  • Mata, Jesus Garcia
  • Gascon, Pere
  • Gasquet, Jose Antonio
  • Herdman, Michael
  • Rodriguez, Cesar A
  • Sanchez, Jordi
  • Valentin, Vicente
... View more Collapse

Value In Health (p. 130-138) - 1/1/2009

10.1111/j.1524-4733.2008.00426.x View at source

  • ISSN 10983015

Prognostic value of cytosolic p53 protein in breast cancer

  • Montero, S
  • Guzman, C
  • Vargas, C
  • Ballestin, C
  • Cortes-Funes, H
  • Colomer, R;

Tumor Biology (p. 337-344) - 1/1/2001

10.1159/000050636 View at source

  • ISSN 10104283

P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with …

  • J Albanell
  • R Colomer
  • M Ruiz-Borrego
  • E Alba
  • JA García Saenz
  • M Martin
  • I Tusquets
  • F Rojo
  • I Faull
  • A Lluch
... View more Collapse

The Breast (p. S43-S43) - 1/1/2011

  • iMarina

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer

  • Baro, Eva
  • Carulla, Joan
  • Cassinello, Javier
  • Colomer, Ramon
  • Garcia Mata, Jesus
  • Gascon, Pere
  • Antonio Gasquet, Jose
  • Rodriguez, Cesar A
  • Valentin, Vicente
... View more Collapse

Supportive Care In Cancer (p. 657-666) - 1/5/2011

10.1007/s00520-010-0878-x View at source

  • ISSN 09414355

Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study

  • Gascon, Pere
  • Rodriguez, Cesar A
  • Valentin, Vicente
  • Mata, Jesus Garcia
  • Carulla, Joan
  • Cassinello, Javier
  • Colomer, Ramon
  • Baro, Eva
... View more Collapse

Supportive Care In Cancer (p. 3039-3049) - 1/11/2013

10.1007/s00520-013-1862-z View at source

  • ISSN 09414355

A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.

  • Hitt, R
  • Hornedo, J
  • Colomer, R
  • Mendiola, C
  • Brandariz, A
  • Sevilla, E
  • AlvarezVicent, J
  • CortesFunes, H;
... View more Collapse

Seminars In Oncology (p. 50-54) - 1/12/1995

  • ISSN 00937754
  • iMarina

Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.

  • Colomer, R
  • Llombart, A
  • Lluch, A
  • Ojeda, B
  • Barnadas, A
  • Caranana, V
  • Fernandez, Y
  • De Paz, L
  • Guillem, V
  • Alonso, S;
... View more Collapse

Seminars In Oncology (p. 20-24) - 4/3/2000

  • ISSN 00937754
  • iMarina

DIRECT INTERACTION OF A LIGAND FOR THE ERBB2 ONCOGENE PRODUCT WITH THE EGF RECEPTOR AND P185ERBB2

  • LUPU, R
  • COLOMER, R
  • ZUGMAIER, G
  • SARUP, J
  • SHEPARD, M
  • SLAMON, D
  • LIPPMAN, ME;
... View more Collapse

Science (p. 1552-1555) - 1/1/1990

10.1126/science.2218496 View at source

  • ISSN 00368075

Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

  • Palacios Calvo J
  • Albanell J
  • Rojo F
  • Ciruelos E
  • Aranda-López I
  • Cortés J
  • García-Caballero T
  • Martín M
  • López-García M
  • Colomer R
... View more Collapse

Revista Espanola De Patologia (p. 97-109) - 1/4/2018

10.1016/j.patol.2017.12.002 View at source

  • ISSN 1988561X

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …

  • M Marangolo
  • I Lang
  • C Beato
  • R Colomer
  • L Ukarma

(p. 388-388) - 1/1/2005

  • iMarina

ESTIMATED COSTS OF LOCOREGIONAL AND METASTATIC RECURRENCES IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN

  • Albanell, J.
  • Ciruelos, E.
  • De la Haba, J.
  • Martin, M.
  • Munoz-Molina, B.
  • De Salas-Cansado, M.
  • Colomer, R.;
... View more Collapse

Value In Health (p. A729-A729) - 1/1/2016

10.1016/j.jval.2016.09.2190 View at source

  • ISSN 10983015

PERFORMANCE AND ADEQUACY OF PATIENT-PERSPECTIVE CRITERIA IN THE ASSESSMENT OF TEST-RETEST RELIABILITY: THE CASE OF THE PERFORM QUESTIONNAIRE

  • Baro, E
  • Rodriguez, C
  • Gascon, P
  • Garcia-Mata, J
  • Colomer, R
  • Cassinello, J
  • Carulla, J
  • Valentin, V
  • Gasquet, J A
... View more Collapse

Value In Health (p. A486-A486) - 1/1/2008

10.1016/s1098-3015(10)66620-x View at source

  • ISSN 10983015

Sensitivity to change of the perform questionnaire (PQ) in cancer patients reporting improvement or deterioration of their cancer-related fatigue

  • Baro, E
  • Cassinello, J
  • Caruiia, J
  • Valentin, V
  • C, Rodriguez
  • Gascon, P
  • J, Garcia-Mata
  • Colomer, R
  • Gasquet, J A
... View more Collapse

Value In Health (p. A343-A344) - 1/1/2007

10.1016/s1098-3015(10)65226-6 View at source

  • ISSN 10983015

Using psychometric and clinimetric techniques to select items for use in a new instrument to measure cancer-related fatigue

  • Baro, E
  • Carulla, J
  • Valentin, V
  • Rodriguez, C
  • Gascon, P
  • Garcia-Mata, J
  • Colomer, R
  • Cassinello, J
  • Herdman, M
  • Gasquet, J A
  • Sanchez, J
... View more Collapse

Value In Health (p. A203-A203) - 1/1/2006

10.1016/s1098-3015(10)63204-4 View at source

  • ISSN 10983015

CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN

  • Ciruelos, E.
  • Alba, E.
  • Lopez, R.
  • Lluch, A.
  • Martin, M.
  • Arroyo, I
  • Navarro, B.
  • Carcedo, D.
  • Colomer, R.
  • Albanell, J.;
... View more Collapse

Value In Health (p. S18-S18) - 1/1/2018

10.1016/j.jval.2018.09.102 View at source

  • ISSN 10983015

COST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAINCO ST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN

  • Colomer, R.
  • Ciruelos, E.
  • De la Haba, J.
  • Martin, M.
  • De Salas-Cansado, M.
  • Munoz-Molina, B.
  • Albanell, J.;
... View more Collapse

Value In Health (p. A740-A740) - 1/1/2016

10.1016/j.jval.2016.09.2249 View at source

  • ISSN 10983015

TREATMENT RATES IN PATIENTS WITH HER2+METASTATIC BREAST CANCER AND THE FACTORS INFLUENCING TREATMENT DECISION

  • Colomer, R.
  • Hall, P.
  • Szkultecka-Debek, M.
  • Bondi, R.
  • Flinois, A.
  • Auziere, S.
  • Le Cleach, J.;
... View more Collapse

Value In Health (p. A764-A765) - 1/1/2016

10.1016/j.jval.2016.09.2386 View at source

  • ISSN 10983015

RESPONSE TO TARGETED THERAPY AND HEALTHCARE RESOURCE UTILIZATION (HRU): A EUROPEAN RETROSPECTIVE CHART REVIEW STUDY IN PATIENTS WITH HER2+METASTATIC BREAST CANCER

  • Colomer, R.
  • Hall, P.
  • Szkultecka-Debek, M.
  • Bondi, R.
  • Flinois, A.
  • Le Cleach, J.;

Value In Health (p. A742-A742) - 1/1/2016

10.1016/j.jval.2016.09.2260 View at source

  • ISSN 10983015

USEFULNESS OF CA-15.3 SERIC LEVELS IN CLINICAL-PRACTICE

  • RUIBAL, A
  • COLOMER, R
  • ROSELL, M
  • GRIS, JM;

Tumour Biology (p. 315-315) - 1/1/1986

  • ISSN 02895447
  • iMarina

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Arranz, R.
  • García-Alfonso, P.
  • Sobrino, P.
  • Zamora, P.
  • Carrión, R.
  • García-Laraña, J.
  • Pérez, G.
  • López, J.
  • Lavilla, E.
  • Lozano, M.
  • Rayón, C.
  • Colomer, R.
  • González Barón, M.
  • Flores, E.
  • Pérez-Manga, G.
  • Fernández-Rañada, J.M.
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater

1/1/1996

  • iMarina

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM